AgeX Therapeutics
Alameda, US · Founded 2017 · Alabama corporation
Biotech
Founders & leadership
AgeX Therapeutics was founded in 2017 by Michael D. West.
MD
Michael D. WestPresident and CEO
RS
Russell SkibstedChief Financial Officer
Board
AK
Alfred KingsleyChairman
MH
Michael H. MulroyBoard director
Reported raises · per SEC filings
Form D private placements$19M disclosed across 5 rounds · 2017–2019
▶$4.5MraisedMar 2019 · 17 investors · BiotechnologyRule 506(b)
▶$4.5MraisedMar 2019 · 17 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Annalisa JenkinsDirector
- Michael D. WestExecutive Officer, Director
- John F. MauldinDirector
- Gregory BaileyDirector
- Not Applicable BioTime, Inc.Promoter
- Michael H. MulroyDirector
- Russell SkibstedExecutive Officer
- Offering amount
- $5M
- Amount sold
- $4.5M
- Proceeds to insiders
- $900K
- First sale
- Mar 2019
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
▶$200KraisedAug 2018 · 1 investors · BiotechnologyRule 506(b)
▶$200KraisedAug 2018 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Michael D. WestExecutive Officer, Director
- Not Applicable BioTime, Inc.Promoter
- Russell SkibstedExecutive Officer
- John MauldinDirector
- Alfred KingsleyExecutive Officer, Director
- Michael H. MulroyDirector
- Amount sold
- $200K
- First sale
- Aug 2018
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
▶$5MraisedJun 2018 · 1 investors · BiotechnologyRule 506(b)
▶$5MraisedJun 2018 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Alfred KingsleyExecutive Officer, Director
- John MauldinDirector
- Michael D. WestExecutive Officer, Director
- Russell SkibstedExecutive Officer
- Not Applicable BioTime, Inc.Promoter
- Michael H. MulroyDirector
- Offering amount
- $5M
- Amount sold
- $5M
- Minimum investment
- $50K
- Proceeds to insiders
- $2.3M
- First sale
- Jun 2018
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
▶$462.5KraisedJan 2018 · 20 investors · BiotechnologyRule 506(b)
▶$462.5KraisedJan 2018 · 20 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Michael H. MulroyDirector
- Russell SkibstedExecutive Officer
- Not Applicable BioTime, Inc.Promoter
- Alfred KingsleyExecutive Officer, Director
- Michael D. WestExecutive Officer, Director
- Offering amount
- $1M
- Amount sold
- $462.5K
- Minimum investment
- $2.5K
- Proceeds to insiders
- $360K
- First sale
- Jan 2018
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
▶$8.8MraisedJul 2017 · 18 investors · BiotechnologyRule 506(b)
▶$8.8MraisedJul 2017 · 18 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Not Applicable BioTime, Inc.Promoter
- Michael D. WestExecutive Officer, Director
- Russell SkibstedExecutive Officer
- Michael H. MulroyDirector
- Alfred KingsleyDirector
- Offering amount
- $10M
- Amount sold
- $8.8M
- Minimum investment
- $50K
- Proceeds to insiders
- $3.6M
- First sale
- Jun 2017
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Non-dilutive funding · 2 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase ISTTR | 2023 | $341K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2018 | $225K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- Who founded AgeX Therapeutics?
- AgeX Therapeutics was founded by Michael D. West in 2017.
- How much funding has AgeX Therapeutics raised?
- AgeX Therapeutics has disclosed $19M raised across 5 rounds.
- Where is AgeX Therapeutics headquartered?
- AgeX Therapeutics is headquartered in Alameda, US.